TIRmed successfully completes key toxicity study

In a recent development, TIRmed has conducted a biodistribution study that has yielded very promising results. The study, focused on dermal applications, marks a significant milestone in the company's ongoing research efforts.

TIRmed Pharma is pleased to announce the appointment of Pirkko Tamsen as a new member of its Board of Directors.